Elvin-Lewis Memory
Washington University, Box 1137 St. Louis MO 63130, USA.
Afr J Tradit Complement Altern Med. 2011;8(5 Suppl):13-26. doi: 10.4314/ajtcam.v8i5S.12. Epub 2011 Jul 3.
As aculturization and globalization continues, there is an urgent need to carefully record and delineate traditional pharmacopeias so that their true worth is understood and protected and any possible benefits related to their commercial development are equitably distributed. In the past most of these endeavors resulted in a list of plants with their associated uses without providing further explanations as to the extent of this knowledge within the traditional group, or if this knowledge was known elsewhere. This practice tended to generate the notion of finite exclusivity without providing proof that this was actually the case. Moreover, since the talents and methods of those conducting these initial studies varied widely, little effort was made to provide adequate information on how selective processes and preferences as well as modes of collection, preparation and use were achieved. Without these data, the potential of their clinical worth, bioreactive capacities or chemical compositions were often compromised. This frequently led to expending much time, effort and treasure on a pharmacopeia's evaluation without guidance on how these efforts could be optimized to achieve its best possible medicinal potential. This paper will review how types of dereplications and other techniques are helpful in amplifying this process.
随着文化交流和全球化的持续发展,迫切需要仔细记录和描述传统药典,以便理解和保护其真正价值,并公平分配与商业开发相关的任何潜在利益。过去,这些努力大多只列出了植物及其相关用途,而没有进一步解释这种知识在传统群体中的普及程度,或者这种知识在其他地方是否为人所知。这种做法往往会产生有限排他性的观念,却没有提供实际情况确实如此的证据。此外,由于开展这些初步研究的人员的才能和方法差异很大,几乎没有努力提供关于如何实现选择过程和偏好以及采集、制备和使用方式的充分信息。没有这些数据,它们的临床价值、生物反应能力或化学成分的潜力往往会受到损害。这常常导致在对药典进行评估时花费大量时间、精力和财力,却没有关于如何优化这些努力以实现其最佳药用潜力的指导。本文将回顾去重类型和其他技术如何有助于加速这一过程。